Valproic Acid Activates the PI3K/Akt/mTOR Pathway in Muscle and Ameliorates Pathology in a Mouse Model of Duchenne Muscular Dystrophy

Goodman and Gilman's the Pharmacological Basis of Therapeutics

William H. Stigelman, D Pharm · Military Medicine · 1986 · 6.8K citations

Medicinal Chemistry, Pharmacological Study, Pharmacology +4

Dystrophin: The protein product of the duchenne muscular dystrophy locus

Eric P. Hoffman, Robert H. Brown, Louis M. Kunkel · Cell · 1987 · 4.6K citations

Protein Function, Biochemistry, Skeletal Muscle +8

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

Sue C. Bodine, Trevor N. Stitt, Michael Gonzalez et al. · Nature Cell Biology · 2001 · 2.7K citations

Skeletal Muscle Hypertrophy, Molecular Physiology, Muscle Injury +10

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

Martin Göttlicher · The EMBO Journal · 2001 · 1.9K citations · Full text

Hdac Inhibitors, Valproic Acid, Transformed Cells +10

Goodman and Gilman's The Pharmacological Basis of Therapeutics

Robert C. Hastings, Gillis W. Long · JAMA · 1991 · 1.1K citations

Philosophy Of Medicine, Alfred Goodman Gilman, Medicinal Chemistry +10